v3.26.1
Revenue Recognition (Tables)
9 Months Ended
Mar. 28, 2026
Revenue Recognition and Deferred Revenue [Abstract]  
Schedule of Concentration Risks
The table below discloses our total net revenue by type of product (in millions, except percentage data):
 Three Months EndedNine Months Ended
 March 28, 2026March 29, 2025March 28, 2026March 29, 2025
Amount% of TotalAmount% of TotalAmount% of TotalAmount% of Total
Components533.3 66.0 %300.8 70.7 %1,356.2 67.5 %$795.9 68.4 %
Systems275.1 34.0 %124.4 29.3 %651.5 32.5 %368.4 31.6 %
Net revenue$808.4 100.0 %$425.2 100.0 %$2,007.7 100.0 %$1,164.3 100.0 %
Schedule of Changes in Contract Balances
The following table reflects the changes in contract balances for the periods presented (in millions, except percentages):
Contract balancesBalance sheet locationMarch 28, 2026June 28, 2025ChangePercentage Change
Accounts receivable, net Accounts receivable, net $441.6 $250.0 $191.6 76.6 %
Deferred revenue and customer deposits (1)
Other current liabilities
$7.3 $0.7 $6.6 942.9 %
Deferred revenue and customer deposits (1)
Other non-current liabilities
$2.2 $— $2.2 n/a
(1) We recorded the total $6.9 million of below-market contract liability related to our acquisition of a business in March 2026 in our consolidated balance sheets, wherein about $6.1 million was recorded as other current liabilities and about $0.8 million was recorded as other non-current liabilities, which will be amortized and recorded as revenue over the term of the supply agreement. During the three and nine months ended March 28, 2026, we have recognized approximately $0.4 million of this amount to revenue. Refer to “Note 4. Business Combinations” for details.